Cel Sci Corp Stock Today

CVM Stock  USD 1.89  0.01  0.53%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 81

 
100  
 
Zero
Very High
CEL SCI is selling at 1.89 as of the 28th of March 2024; that is 0.53 percent up since the beginning of the trading day. The stock's lowest day price was 1.84. CEL SCI has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for CEL SCI Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of January 1987
Category
Healthcare
Classification
Health Care
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange.. The company has 53.98 M outstanding shares of which 6.98 M shares are currently shorted by investors with about 16.41 days to cover. More on CEL SCI Corp

Moving together with CEL Stock

  0.65MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.61MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.73KA Kineta Inc Report 29th of March 2024 PairCorr

Moving against CEL Stock

  0.78TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
  0.77MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.67MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.65DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.6VANI Vivani Medical Report 29th of March 2024 PairCorr
  0.56MESO Mesoblast TrendingPairCorr

CEL Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CEL SCI's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CEL SCI or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOGeert Kersten
Old Names[CVR Medical Corp, CROWN MEDIA HLDG-A - Frankfurt Stock Exchang]
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering CEL SCI report their recommendations after researching CEL SCI's financial statements, talking to executives and customers, or listening in on CEL SCI's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering CEL-SCI Corp. The CEL consensus assessment is calculated by taking the average forecast from all of the analysts covering CEL SCI.
Financial Strength
Based on the key indicators obtained from CEL SCI's historical financial statements, CEL SCI Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. Financial strength of CEL-SCI Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.01510.0158
Sufficiently Down
Slightly volatile
Total Current Liabilities3.6 M6.4 M
Way Down
Slightly volatile
Non Current Liabilities Total14.2 M13.5 M
Sufficiently Up
Slightly volatile
Total Assets36.9 M35.1 M
Sufficiently Up
Slightly volatile
Total Current Assets9.9 MM
Fairly Up
Slightly volatile
CEL SCI's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CEL SCI's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CEL SCI's financial leverage. It provides some insight into what part of CEL SCI's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on CEL SCI's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how CEL SCI deploys its capital and how much of that capital is borrowed.
Liquidity
CEL SCI cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 13.57 M in debt with debt to equity (D/E) ratio of 0.41, which is OK given its current industry classification. CEL-SCI Corp has a current ratio of 7.56, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist CEL SCI until it has trouble settling it off, either with new capital or with free cash flow. So, CEL SCI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CEL-SCI Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CEL to invest in growth at high rates of return. When we think about CEL SCI's use of debt, we should always consider it together with cash and equity.

Capital Expenditures

689,710
CEL SCI Corp (CVM) is traded on NYSE MKT Exchange in USA. It is located in 8229 Boone Boulevard, Vienna, VA, United States, 22182 and employs 12 people. CEL SCI is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 102.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CEL SCI's market, we take the total number of its shares issued and multiply it by CEL SCI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CEL-SCI Corp runs under Biotechnology sector within Health Care industry. The entity has 53.98 M outstanding shares of which 6.98 M shares are currently shorted by investors with about 16.41 days to cover. CEL SCI Corp has about 22.67 M in cash with (22.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65.
Check CEL SCI Probability Of Bankruptcy
Ownership Allocation
CEL-SCI Corp retains a total of 53.98 Million outstanding shares. CEL SCI Corp shows 3.19 percent of its outstanding shares held by insiders and 12.45099999999999 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check CEL Ownership Details

CEL Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of CEL SCI jumping above the current price in 90 days from now is under 95%. The CEL SCI Corp probability density function shows the probability of CEL SCI stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.2725 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CEL SCI will likely underperform. Additionally, cEL SCI Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 1.89HorizonTargetOdds Above 1.89
5.38%90 days
 1.89 
94.59%
Based on a normal probability distribution, the odds of CEL SCI to move above the current price in 90 days from now is under 95 (This CEL SCI Corp probability density function shows the probability of CEL Stock to fall within a particular range of prices over 90 days) .

CEL SCI Historical Income Statement

CEL SCI Corp Income Statement is one of the three primary financial statements used for reporting CEL's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CEL-SCI Corp revenue and expense. CEL SCI Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, CEL SCI's Reconciled Depreciation is very stable compared to the past year. View More Fundamentals

CEL Stock Against Markets

Picking the right benchmark for CEL SCI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CEL SCI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CEL SCI is critical whether you are bullish or bearish towards CEL SCI Corp at a given time. Please also check how CEL SCI's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CEL SCI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

CEL SCI Corporate Directors

CEL SCI corporate directors refer to members of a CEL SCI board of directors. The board of directors generally takes responsibility for the CEL SCI's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of CEL SCI's board members must vote for the resolution. The CEL SCI board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Peter YoungIndependent DirectorProfile
Robert WatsonIndependent DirectorProfile
Alexander EsterhazyIndependent DirectorProfile
Bruno BaillavoineIndependent DirectorProfile

How to buy CEL Stock?

Before investing in CEL SCI, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in CEL SCI. To buy CEL SCI stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of CEL SCI. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase CEL SCI stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located CEL SCI Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased CEL SCI Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as CEL SCI Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy CEL Stock please use our How to Invest in CEL SCI guide.

Already Invested in CEL SCI Corp?

The danger of trading CEL SCI Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CEL SCI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CEL SCI. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CEL-SCI Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether CEL-SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for CEL Stock analysis

When running CEL SCI's price analysis, check to measure CEL SCI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CEL SCI is operating at the current time. Most of CEL SCI's value examination focuses on studying past and present price action to predict the probability of CEL SCI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CEL SCI's price. Additionally, you may evaluate how the addition of CEL SCI to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is CEL SCI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.52)
Return On Equity
(1.58)
The market value of CEL-SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.